Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Fuisz Announces a New Lozenge Product to Enhance E-cigarette Tobacco Satisfaction As Well As THC Delivery From Medical Marijuana

MIAMI, Jan. 8, 2013 /PRNewswire/ -- Fuisz LLC today announced that it will launch a new oral pre-product in the form of a lozenge in early 2013 designed to enhance tobacco satisfaction from electronic cigarettes, as well as to enhance THC absorption from medical marijuana.   The product is protected by a patent pending.

Joseph Fuisz, Managing Member of Fuisz, commented, "The extraordinary growth in electronic cigarette consumption at the expense of conventional cigarettes is perceived as large net positive for public health.  However, the e-cigarette industry is still struggling to enhance tobacco satisfaction from what is essentially a buccal delivery product.  That means that nicotine absorption is occurring across the oral mucosa in the mouth as opposed to the lung.  As a result, the nicotine levels delivered by an e-cigarette are much lower (Cmax) and slower to build (Tmax) than the nicotine levels delivered by a traditional cigarette.  Our new oral dosage unit contains a number of agents designed to enhance the speed and level of tobacco satisfaction from the electronic cigarette. Best of all, the product works dramatically."

Mr. Joseph Fuisz continued:  "Our lozenge product itself contains no tobacco, nicotine or other active drug ingredient. We intend to market our product under our own trade name – to be announced -- through conventional retail channels."

Dr. Richard Fuisz (http://en.wikipedia.org/wiki/Richard_Fuisz), Fuisz founder, remarked: "We have invented and developed an oral pre-product which is easy and pleasant to use, and enhances delivery for medical marijuana users who vaporize their material. The user simply uses the pre-product while vaporizing the medical marijuana. Consistent with the macro trend in pharmaceutical drug delivery toward more effective smaller dosing, this advance allows for lower dosing with the same medicinal effect from a lesser amount of vaporized THC. The growth of medical marijuana, and in particular the growth of vaporization of medical marijuana has been recognized by global authorities including Health Canada to result in a smaller toxicant profile than the conventional smoking of marijuana, and hence the need to maximize its efficiency."

Fuisz LLC is a private technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology and diagnostic applications. Fuisz has extensive experience working with big and specialty pharma, as well as large consumer products companies. Fuisz has its headquarters in Miami. www.fuisz.com

SOURCE Fuisz LLC

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
Cloud Foundry open Platform as a Service makes it easy to operate, scale and deploy application for your dedicated cloud environments. It enables developers and operators to be significantly more agile, writing great applications and deliver them in days instead of months. Cloud Foundr...
Silver shows that predictions in areas such as economics have been less successful, e.g. he examines why many economists missed the recession, and why supposedly expert forecasters get election predictions wrong so often. For example, before the recession of 2008, the assumption was ma...
The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is ob...
You can then easily piece together full transaction traces by ordering all method calls by sequence number. Further analysis can be applied to this information for a number of purposes. For example, by analysing the transactions, developers can easily construct design diagrams that can...
Every day and every second, the system administrator gets tones of information on the network operation, network devices’ operation, and messages from users; he sets dozens of challenges, which must help to avoid the existing and possible problems in the future. Often, it is rather dif...
With the increasing complexity of software, organizations are more cognizant than ever about the potential pitfalls of including open source code in their products. Below are some quick tips to continue leveraging open source code, while keeping your manager and legal department happy.
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE